Mergers & Acquisitions - Shire, Financial

Filter

Current filters:

ShireFinancial

Popular Filters

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

Shire’s acquisition of ViroPharma will add $831m in revenue by 2018, says GlobalData

19-11-2013

Ireland-based drugmaker Shire’s (LSE: SHP) buy-out of US orphan drug company ViroPharma (Nasdaq: VPHM)…

CinryzeEuropeFinancialMergers & AcquisitionsPharmaceuticalShireUSAViroPharma

AstraZeneca management shakeup sign of major restructuring leading to stock recovery, say analysts

17-01-2013

The management changes at Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced this week do not…

AstraZenecaBrilintaBriliqueFinancialManagementMergers & AcquisitionsPharmaceuticalShire

Parexel

Parexel

Back to top